Concord Wealth Partners’s Protolabs PRLB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q1
Sell
-19
Closed -$485 1166
2022
Q4
$485 Buy
+19
New +$564 ﹤0.01% 1153
2022
Q3
Sell
-19
Closed -$1K 874
2022
Q2
$1K Sell
19
-543
-97% -$25.2K ﹤0.01% 1176
2022
Q1
$30K Sell
562
-71
-11% -$3.74K 0.01% 545
2021
Q4
$33K Buy
633
+357
+129% +$21.1K 0.01% 532
2021
Q3
$18K Sell
276
-669
-71% -$52.3K 0.01% 394
2021
Q2
$87K Sell
945
-209
-18% -$20.6K 0.02% 259
2021
Q1
$140K Buy
1,154
+1,135
+5,974% +$189K 0.05% 167
2020
Q4
$3K Buy
+19
New +$2.68K ﹤0.01% 487

Other funds holding PRLB

Concord Wealth Partners's PRLB Position: Q1 2023 in Review

Concord Wealth Partners sold out of Protolabs (PRLB) in Q1 2023, closing a stake of 19 shares — an estimated $485 sold.

Concord Wealth Partners first reported a position in PRLB in Q4 2020 and held it in 8 quarters. The position peaked at $140K in Q1 2021. 198 funds tracked by Wall St. Rank hold PRLB as of Q1 2023.

  • Concord Wealth Partners reported no remaining Protolabs position as of Q1 2023 after selling out during the quarter.
  • Concord Wealth Partners sold 19 Protolabs shares in Q1 2023, an estimated $485.
  • Concord Wealth Partners first reported a position in Protolabs in Q4 2020 and held it in 8 quarters.
  • Concord Wealth Partners's Protolabs position peaked at $140K in Q1 2021.
  • 198 funds tracked by Wall St. Rank held Protolabs as of Q1 2023.

Based on Concord Wealth Partners's 13F filing for Q1 2023, filed 26 Apr 2023.